CLINICAL_TRIALS
trial_result
· 2013-08-02
Clinical Trial Update: An Efficacy and Safety Study of Paliperidone Extended-Release (ER) Tablets in Participants With Schizophrenia [Phase 3]
Summary
This update reports the completion and posted results of a Phase 3 trial evaluating the efficacy and safety of paliperidone ER tablets in schizophrenia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen-Cilag International NV | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2013-08-02